EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 34 / No 8-9 (Août–Septembre 2018) Med Sci (Paris), 34 8-9 (2018) 693-700 References
Open Access
Issue
Med Sci (Paris)
Volume 34, Number 8-9, Août–Septembre 2018
Les Cahiers de Myologie
Page(s) 693 - 700
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20183408016
Published online 19 September 2018
  1. Petruzziello A. Epidemiology of hepatitis B virus (HBV) and hepatitis C virus (HCV) related hepatocellular carcinoma. Open Virol J 2018 ;12 : 26–32. [CrossRef] [PubMed] [Google Scholar]
  2. Seeger C, Mason WS. Molecular biology of hepatitis B virus infection. Virology 2015 ; 479-480 : 672–686. [CrossRef] [PubMed] [Google Scholar]
  3. Yan H, Zhong G, Xu G, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 2012 ; 3. [Google Scholar]
  4. European Association for the Study of the Liver. Electronic address eee, European association for the study of the L. EASL 2017 Clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol 2017 ; 67 : 370–398. [CrossRef] [PubMed] [Google Scholar]
  5. Chisari FV, Isogawa M, Wieland SF. Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris) 2010 ; 58 : 258–266. [CrossRef] [PubMed] [Google Scholar]
  6. Chang MH, Chen DS. Prevention of hepatitis B. Cold Spring Harb Perspect Med 2015 ; 5 : a021493. [CrossRef] [Google Scholar]
  7. Rijckborst V, Janssen HL. The role of interferon in hepatitis B therapy. Curr Hepat Rep 2010 ; 9 : 231–238. [CrossRef] [PubMed] [Google Scholar]
  8. Zlotnick A, Venkatakrishnan B, Tan Z, et al. Core protein : a pleiotropic keystone in the HBV lifecycle. Antiviral Res 2015 ; 121 : 82–93. [CrossRef] [PubMed] [Google Scholar]
  9. Chu TH, Liou AT, Su PY, et al. Nucleic acid chaperone activity associated with the arginine-rich domain of human hepatitis B virus core protein. J Virol 2014 ; 88 : 2530–2543. [CrossRef] [PubMed] [Google Scholar]
  10. Watts NR, Conway JF, Cheng N, et al. The morphogenic linker peptide of HBV capsid protein forms a mobile array on the interior surface. EMBO J 2002 ; 21 : 876–884. [CrossRef] [PubMed] [Google Scholar]
  11. Diab A, Foca A, Zoulim F, et al. The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle : Implications for the development of HBc-targeting antivirals. Antiviral Res 2018 ; 149 : 211–220. [CrossRef] [PubMed] [Google Scholar]
  12. Ricco R, Kanduc D. Hepatitis B virus and Homo sapiens proteome-wide analysis : a profusion of viral peptide overlaps in neuron-specific human proteins. Biologics 2010 ; 4 : 75–81. [PubMed] [Google Scholar]
  13. Diab A, Foca A, Fusil F, et al. Polo-like-kinase 1 is a proviral host factor for hepatitis B virus replication. Hepatology 2017 ; 66 : 1750–1765. [CrossRef] [PubMed] [Google Scholar]
  14. Gallucci L, Kann M. Nuclear Import of hepatitis B virus capsids and genome. Viruses 2017 ; 9. [Google Scholar]
  15. Faure-Dupuy S, Lucifora J, Durantel D. Interplay between the hepatitis B virus and innate immunity : from an understanding to the development of therapeutic concepts. Viruses 2017 ; 9. [Google Scholar]
  16. Zhang X, Lu W, Zheng Y, et al. In situ analysis of intrahepatic virological events in chronic hepatitis B virus infection. J Clin Invest 2016 ; 126 : 1079–1092. [CrossRef] [PubMed] [Google Scholar]
  17. Bock CT, Schwinn S, Locarnini S, et al. Structural organization of the hepatitis B virus minichromosome. J Mol Biol 2001 ; 307 : 183–196. [Google Scholar]
  18. Guo YH, Li YN, Zhao JR, et al. HBc binds to the CpG islands of HBV cccDNA and promotes an epigenetic permissive state. Epigenetics 2011 ; 6 : 720–726. [CrossRef] [PubMed] [Google Scholar]
  19. Belloni L, Li L, Palumbo GA, et al. HAPs hepatitis B virus (HBV) capsid inhibitors block core protein interaction with the viral minichromosome and host cell genes and affect cccDNA transcription and stability. Hepatol 2013 ; 58 : 277A. [Google Scholar]
  20. Zhang W, Chen J, Wu M, et al. PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation. Hepatology 2017 ; 66 : 398–415. [CrossRef] [PubMed] [Google Scholar]
  21. Lubyova B, Hodek J, Zabransky A, et al. PRMT5 : a novel regulator of Hepatitis B virus replication and an arginine methylase of HBV core. PLoS One 2017 ; 12 : e0186982. [CrossRef] [PubMed] [Google Scholar]
  22. Guo Y, Kang W, Lei X, et al. Hepatitis B viral core protein disrupts human host gene expression by binding to promoter regions. BMC Genomics 2012 ; 13 : 563. [CrossRef] [PubMed] [Google Scholar]
  23. Kwon JA, Rho HM. Transcriptional repression of the human p53 gene by hepatitis B viral core protein (HBc) in human liver cells. Biol Chem 2003 ; 384 : 203–212. [PubMed] [Google Scholar]
  24. Du J, Liang X, Liu Y, et al. Hepatitis B virus core protein inhibits TRAIL-induced apoptosis of hepatocytes by blocking DR5 expression. Cell Death Differ 2009 ; 16 : 219–229. [CrossRef] [PubMed] [Google Scholar]
  25. Yang CC, Huang EY, Li HC, et al. Nuclear export of human hepatitis B virus core protein and pregenomic RNA depends on the cellular NXF1-p15 machinery. PLoS One 2014 ; 9 : e106683. [CrossRef] [PubMed] [Google Scholar]
  26. Rabe B, Delaleau M, Bischof A, et al. Nuclear entry of hepatitis B virus capsids involves disintegration to protein dimers followed by nuclear reassociation to capsids. PLoS Pathog 2009 ; 5 : e1000563. [Google Scholar]
  27. Nassal M. The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J Virol 1992 ; 66 : 4107–4116. [PubMed] [Google Scholar]
  28. Wang XY, Wei ZM, Wu GY, et al. In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations. Antivir Ther 2012 ; 17 : 793–803. [CrossRef] [PubMed] [Google Scholar]
  29. Bourne C, Lee S, Venkataiah B, et al. Small-molecule effectors of hepatitis B virus capsid assembly give insight into virus life cycle. J Virol 2008 ; 82 : 10262–10270. [CrossRef] [PubMed] [Google Scholar]
  30. Guo F, Zhao Q, Sheraz M, et al. HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways. PLoS Pathog 2017 ; 13 : e1006658. [CrossRef] [PubMed] [Google Scholar]
  31. Huber AD, Wolf JJ, Liu D, et al. The heteroaryldihydropyrimidine bay 38-7690 induces hepatitis B virus core protein aggregates associated with promyelocytic leukemia nuclear bodies in infected cells. mSphere 2018 ; 3. [Google Scholar]
  32. Lahlali T, Berke JM, Vergauwen K, et al. Novel potent capsid assembly modulators regulate multiple steps of the hepatitis B virus life-cycle. Antimicrob Agents Chemother 2018 Jul 16. pii: AAC.00835-18. doi: 10.1128/AAC.00835-18. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.